Clinical trial
A Phase II Study of Total Neoadjuvant Therapy in Rectal Cancer
NCT06162650 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Total Neoadjuvant Therapy in Rectal Cancer
- Lead sponsor
- National Cheng-Kung University Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 16, 2023
- Completion date
- November 16, 2030
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer